Humphrey, M., Chen, N., Xiong, Y., Marchion, D., Bicaku, E., Chon, H., … Lancaster, J. (2010). Genomic analysis defines biological pathway differences between early- and advanced-stage ovarian cancers. GYNECOLOGIC ONCOLOGY, 116(3), S22–S22.

Humphrey, M., N. Chen, Y. Xiong, D. Marchion, E. Bicaku, H. Chon, A. Berchuck, et al. “Genomic analysis defines biological pathway differences between early- and advanced-stage ovarian cancers.” GYNECOLOGIC ONCOLOGY 116, no. 3 (March 1, 2010): S22–S22.

Humphrey M, Chen N, Xiong Y, Marchion D, Bicaku E, Chon H, et al. Genomic analysis defines biological pathway differences between early- and advanced-stage ovarian cancers. GYNECOLOGIC ONCOLOGY. 2010 Mar 1;116(3):S22–S22.

Humphrey, M., et al. “Genomic analysis defines biological pathway differences between early- and advanced-stage ovarian cancers.” GYNECOLOGIC ONCOLOGY, vol. 116, no. 3, ACADEMIC PRESS INC ELSEVIER SCIENCE, Mar. 2010, pp. S22–S22.

Humphrey M, Chen N, Xiong Y, Marchion D, Bicaku E, Chon H, Berchuck A, Bansal N, Apte S, Wenham R, Lancaster J. Genomic analysis defines biological pathway differences between early- and advanced-stage ovarian cancers. GYNECOLOGIC ONCOLOGY. ACADEMIC PRESS INC ELSEVIER SCIENCE; 2010 Mar 1;116(3):S22–S22.